biopoly - isakos cartilage symposium - shanghai june 2017

55
Prof. Vladimir Bobić MD FRCSEd, Consultant Orthopaedic Knee Surgeon Chester Knee Clinic at Nuffield Health, The Grosvenor Hospital Chester, United Kingdom www.kneeclinic.info [email protected] @ChesterKnee BioPoly ® RS Knee System The partial resurfacing implant 1

Upload: vladimir-bobic

Post on 21-Jan-2018

195 views

Category:

Health & Medicine


3 download

TRANSCRIPT

Prof. Vladimir BobićMD FRCSEd, Consultant Orthopaedic Knee Surgeon

Chester Knee Clinic at Nuffield Health, The Grosvenor Hospital Chester, United Kingdomwww.kneeclinic.info [email protected] @ChesterKnee

BioPoly®RS Knee System The partial resurfacing implant

1

Relevant Disclosures

1: Royalties received from Schwartz Biomedical3b: Paid Consultant for intellectual property (implant

and instrument design), Schwartz Biomedical

2

Mr Mike McNicholasBSc, MD, FRCSEd(Tr&Orth), FFSEM RSCI

Consultant, University Hospital Aintree, LiverpoolHon Prof, Directorate of Sport, University of Salford

Hon Senior Lecturer, Department of Musculoskeletal Biology, University of Liverpool

BioPoly®RS Knee System

The partial resurfacing implant

Cardiff, 3rd February 2017

3

@BioKneeSociety

Articular Cartilage Repair: Surgical Options

ACI/MACI

BioPoly: Filling the Void?

OATSMicrofracture

Allografts UKR & TKR4

BioPoly Femoral Resurfacing Implant

Articular Component: Patented Combination UHMWPE + HA5

Poly vs BioPoly

Wetability Hydrophilic

6

Self-lubricating material for better wear

7

• BioPoly® Material– “Microcomposite” (UHMWPE and Hyaluronic Acid)– Hydrophilic (water attracting) polymer

• Hyaluronic Acid within BioPoly®– Attracts synovial fluid for lubrication– Allows for articulation with cartilage

• No damage to opposing cartilage surfaces• No damage to implant surface

• Resurfacing Applications

BioPoly® Technology Overview

Hyaluronic Acid

8

Material properties

9

Material Density Modulus Poisson’s ratio Hyperelastic

Trabecular bone 1.8 g/cc1 1.15 GPa 0.22 NA

Cartilage 1 g/cc 10 MPa 0.495 (incompressible)

Neo HookeC10 = 1.672 MPa,

D1 = 0.0

Titanium 4.5 g/cc3 103 GPa 0.343 NA

Co-Cr 8.41 g/cc3 233 GPa 0.3 NA

UHMWPE (unhydrated) 0.945 g/cc4 830 MPa 0.464 NA

1 http://silver.neep.wisc.edu/~lakes/BoneTrab.html2 van Rietbergen B, Majumdar S, Pistoia W, et al. Assessment of cancellous bone mechanical properties from micro-FE models based on micro-CT, pQCT and MR images. Technol Health Care. 1998;6:413–420.3 http://www.fwmetals.com/titanium-wire-alloys.php4 http://www.goodfellow.com/E/Polyethylene-UHMW.html

FEA Comparison of Partial Resurfacing Femoral Implants: BioPoly RS and a metallic implant

• Contact biomechanics between femoral condyle focal defect implant and the opposing tibial articulating surface.

• Resulting biomechanical interface: Reduced contact stresses and strains

10

Results: Compressive Strains

11

Metallic Implant Compressive Log strains at the tibial

surface below implant apex

Peak -0.3

BioPoly Compressive Log Strains at the tibial

surface below implant apexPeak -0.100

Additional load sharing zones

BioPoly loading FEA

12

BioPoly - Deformed shape at 1000N (note larger area of tibial cartilage engaged in load sharing)

13

Results in lower opposing cartilage contact pressure (2.5x body weight load)

BioPoly Tibial Cartilage

Contact Pressure

Peak = 3.46 MPa

Active Contact Zone Loaded Area ~ 471

mm2

Metal Implant Tibial Cartilage

Contact Pressure

Peak = 7.24 MPa

Active Contact Zone Loaded Area ~ 314 mm2

14

®Confidential

BioPoly RS Knee and Patella System

• CE Marked• Suitable for cartilage defects in the distal

femur and patella up to 3.1 cm2

• Femoral Condyle and Trochlear Facet Implants

– Ti64 grit blasted stems. Press fit or cemented• Patella implants

– All BioPoly construction for cementation• Simple surgical instrument set and

technique• Existing reimbursement codes

Femoral Condyles and Trochlear Facets

Patella15mm 20mm 15x24mm

15mm/0 15mm/1 20mm/0 20mm/1

15

BioPoly RS Knee Surgical Technique

16

17

The Race-track BioPoly RS Knee Surgical Technique

BioPoly Surgical Technique

18

BioPoly Surgical Technique

19

20

BioPoly RS Knee Surgical Technique

21

BioPoly RS Knee Surgical Technique

22

BioPoly RS Knee Surgical Technique

23

BioPoly RS Knee Surgical Technique

24

BioPoly RS Knee Surgical Technique

25

BioPoly RS Knee Surgical Technique

26

BioPoly RS Knee Surgical Technique

27

BioPoly RS Knee Surgical Technique

28

BioPoly RS Knee Surgical Technique

29

BioPoly RS Knee Surgical Technique

30

BioPoly RS Knee Surgical Technique

31

BioPoly RS Knee Surgical Technique

Race-track BioPoly

32

33

Patellar BioPoly

34

Patellar BioPoly

35

Cemented all BioPoly Implant

36

Current BioPoly® RS Partial Resurfacing3 Families of Products

BioPoly® RS KNEECE Marked

BioPoly® RS PATELLACE Marked

BioPoly® RS SHOULDERCE Marked

Patella HumeralheadDistal Femur

37+ BioPoly® RS Femoral Trochlea and Talar Dome in the pipeline

BioPoly® RS Partial Resurfacing Knee Implantations

5 yrs

600+ cases

38

BioPoly® RS Partial Resurfacing Knee SystemTypical Resurfacing Patient

▪ 21+ year old active adult▪ Knee pain▪ Too young for TKR▪ Often failed Debridement, Microfracture,

OATS or ACI▪ Patients wanting to regain active lifestyle

▪ Focal defects ▪ Femoral condyles

39

Preoperative knee imaging

+ MRI and Arthroscopy for lesional characteristics

40

Indications : Lesion Characteristics• Medial or Lateral femoral condyle, NOT tibial condyles

• Focal 2cm2 or (2.4 x 1.5) cm2 ≤3.1cm2 (Entire lesion visualized in static knee through static arthroscope)

• ICRS grade 2, 3, or 4

• Contained ICRS 0/1

• Depth from articular surface < 4mm

• Good subchondral bone (MRI)

X41

Contradictions Lesion characteristics:

• Uncontained• Very large• >1 implant required• Kissing lesion

42

Contradictions Other joint pathology

• Malalignment

• Laxity

• Major meniscal deficiency

• Subchondral sclerosis

• Advanced degenerative changes43

Registry Study: Preliminary Report

44

Study Investigators and Collaborators:Prof Vladimir Bobic - Chester Knee Clinic, Chester, UKProf Mike McNicholas – Aintree, Liverpool, UKMr Dinesh Nathwani - Imperial College, London, UKProf Alister Hart - RNOH Stanmore, London, UKMr Jonathan Miles - RNOH Stanmore, London, UKMatt Hill - Schwartz Biomedical, USAHerb Schwartz - Schwartz Biomedical, USA

45

Registry Study Design• Study Type: Post-market registry• 35 patients & 4 UK Centres• Control: Historical microfracture outcomes• Outcome measures: KOOS, VAS, Tegner, SF-36

46

Major Inclusion and Exclusion CriteriaInclusion Criteria   Exclusion Criteria• Age 21 years and older • Body Mass Index (BMI) ≥ 30• Symptomatic lesions classified as ICRS grade 2, 3, or 4 • Generalized degenerative or autoimmune arthritis

• Lesion size ≤ 3.1cm2 circumscribed by normal or nearly normal (ICRS grade 0 or 1) cartilage with an overall depth ≤ 4mm from the articulating surface

• Uncorrected chronic malalignment of the knee*• Uncorrected ligamentous instability*• Uncorrected mechanically symptomatic meniscal tear or total meniscectomy*

• Sufficient subchondral bone quality to support implant • Kissing lesion on tibia• More than one implant required to accommodate lesion• Use with opposing articulating tibial components*Can be corrected during surgery

47

Registry Study Results

• Interim results after 2 years indicate:– Significant improvement in

all clinical outcomes– One revision (2.9%) due to

subchondral bone disorder– No differences between

younger and older patients

• Mean Defect size = 2.7cm2

• Over half of patient population (54.3%) failed previous cartilage repair procedures

48

Rotation of BioPoly Implant

49

Failed BioPoly Implant• Why? No structural or technical problems identified. No infection. Patient selection? Surgical technique?• Very difficult to remove! Revised successfully with deep subchondral drilling + ChondroTissue patch.• Possible reasons: inadequate osseous support (previous microfractures + failed MACI = failure of implant

to bone integration)

50

Patient Adverse Events

• 1 Wound infection reported after 1/12– Resolved quickly with medication

• 1 Patient began experiencing pain at 3/12– Arthroscopy revealed implant intact, and loose

cartilage body as source of pain– Removal of loose cartilage body resolved

2symptoms

51

Registry Study Results

• BioPoly compared to historical microfracture outcomes– BioPoly patients on average 7 – 9 years older

• Significantly superior KOOS QoL and Sport after 2 years52

53

Registry Study Results

54

OrthoBiologics vs Metal and Plastic

Hmmm ... not really. Not so soon, but will happen ... 55